MedTrace Logo

Viral Pathogenesis of Early Cystic Fibrosis Lung Disease

NCT01973192 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2017-04-04

No results posted yet for this study

Summary

The purpose of this study is to test the hypothesis that early viral infections alter the bacterial flora and inflammatory profile in the airway and accelerate progression of pulmonary disease in infants with cystic fibrosis.

Conditions

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Indiana University School of Medicine

    lead OTHER

Principal Investigators

  • Stephanie D. Davis, MD · Indiana University School of Medicine

Eligibility

Min Age
2 Months
Max Age
4 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2016-12-01
Completion
2016-12-01

Countries

  • United States
  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01973192 on ClinicalTrials.gov